4’-溴-3’-氟乙酰苯胺 | 351-30-4

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4’-溴-3’-氟乙酰苯胺
• 中文别名: 4'-溴-3'-氟乙酰苯胺
• 英文名称: N-(4-bromo-3-fluorophenyl)acetamide
• 英文别名: 4'-Bromo-3'-fluoroacetanilide
• CAS: 351-30-4
• 化学式: C₈H₇BrFNO
• 分子量: 232.052
• InChiKey: GAQUWJRFYLETKX-UHFFFAOYSA-N

物化性质

• 熔点：
  149-152°C
• 沸点：
  337.9±32.0 °C(Predicted)
• 密度：
  1.623±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S22,S36/37/39
• 危险类别码：
  R22
• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P280,P305+P351+P338,P304+P340,P405,P501
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4’-Bromo-3’-fluoroacetanilide
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4’-Bromo-3’-fluoroacetanilide
Ingredient name:
CAS number: 351-30-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H7BrFNO
Molecular weight: 232.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4’-溴-3’-氟乙酰苯胺 在 硫酸 、 potassium nitrate 、 盐酸 、 碳酸氢钠 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 0.33h， 以45%的产率得到4-溴-5-氟-2-硝基苯甲胺
  参考文献：
  名称：

  [EN] FUSED PYRAZINE DERIVATIVES AS KINASE INHIBITORS
  [FR] DÉRIVÉS DE PYRAZINE FUSIONNÉS EN TANT QU'INHIBITEURS DE KINASE

  摘要：

  公开号：

  WO2010052448A3
• 作为产物：
  描述：

  N-溴代丁二酰亚胺(NBS) 以 二氯甲烷 为溶剂， 以20.40 g (100%)的产率得到4’-溴-3’-氟乙酰苯胺
  参考文献：
  名称：

  Anisotropic organic compounds

  摘要：

  该发明描述了液晶化合物或式(I)，其中A、D和G分别选自苯基、噻吩、氢化苯基、氯化苯基和氟化苯基，B和E分别选自单键C.dbd..notident.C、C.tbd.C.COO、偶氮基和重氮基，k和m分别选自1和0，使得m+n为1或2，R.sub.1和R.sub.2分别选自R、R0、炔基、硫代烷基、氢、CN、NCS和SCN；条件是R.sub.1和R.sub.2中至少有一个选自CN、NCS和SCN，且A、D和G中至少有一个为苯基；并且排除当R.sub.1和R.sub.2中至少有一个独立选择为CN，且A、D或G中至少有一个不是噻吩时，以及当m为0时，A和D为苯基，B为单键，且R.sub.1或R.sub.2仅有一个为NCS。还描述了适合用于利用液晶材料在各向同性相中的前转变特性的装置中的化合物，其通式为(II)，其中J和Y分别选自苯基、噻吩、氢化苯基、氯化苯基和氟化苯基，X选自C.dbd..notident.C、C.tbd.C.COO、偶氮基和重氮基，k为1或0，R.sub.3和R.sub.4分别选自R、RO、炔基、硫代烷基、氢、CN、NCS和SCN；条件是R.sub.3和R.sub.4中至少有一个选自CN、NCS和SCN，且J和Y中至少有一个为苯基。

  公开号：

  US05888421A1

文献信息

• Combining Eosin Y with Selectfluor: A Regioselective Brominating System for <i>Para</i>-Bromination of Aniline Derivatives
  作者：Binbin Huang、Yating Zhao、Chao Yang、Yuan Gao、Wujiong Xia

  DOI：10.1021/acs.orglett.7b01427

  日期：2017.7.21

  A mild, metal-free, and absolutely para-selective bromination of aniline derivatives has been developed in excellent yields, wherein the organic dye Eosin Y is employed as the bromine source in company with Selectfluor. Neither air nor moisture sensitive, this facile reaction proceeds smoothly at room temperature and completes within a short time. Mechanistic studies indicate a radical pathway; therefore

  已开发出具有优异收率的温和，无金属且绝对对位选择性的苯胺衍生物溴化物，其中有机染料曙红Y与Selectfluor一起用作溴源。无论是对空气还是对湿气都不敏感，这种反应很容易在室温下进行并在短时间内完成。机理研究表明了一条根本途径。因此，的原位产生的溴化试剂的存在，“Selectbrom”，是假设，可合理解释为独特区域选择性段的-bromination Ñ -acyl-以及Ñ -sulfonylanilines。
• A <i>para</i> -C-H Functionalization of Aniline Derivatives via In situ Generated Bulky Hypervalent Iodinium Reagents
  作者：Chao Tian、Xu Yao、Weizhe Ji、Qian Wang、Guanghui An、Guangming Li

  DOI：10.1002/ejoc.201801058

  日期：2018.11.25

  A general para‐selective C‐H functionalization was achieved via a steric control strategy. Para‐iodo, bromo, chloro, nitro, and trifluormethyl aniline derivatives were prepared via in situ generated, bulky hypervalent iodinium reagents in as little as 10 min. Products can be purified without column chromatography or recrystallization, which significantly reduces the waste and simplifies the work‐up

  通过空间控制策略可实现一般的对选择性C-H功能化。对碘，溴，氯，硝基和三氟甲基苯胺衍生物可在短短10分钟内通过原位生成的大体积高价碘试剂制备。无需柱色谱或重结晶即可纯化产品，从而大大减少了浪费并简化了后处理过程。
• [EN] SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY<br/>[FR] DÉRIVÉS D'OXINDOLE SPIRO-SUBSTITUÉS AYANT UNE ACTIVITÉ SUR AMPK
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2014202580A1

  公开（公告）日：2014-12-24

  The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

  本发明涉及具有有价值的药理特性的式(I)化合物，特别是AMPK激活剂，因此在治疗某些可以通过激活该受体预防或治疗的疾病方面具有用处。这些化合物适用于治疗和预防可以受该受体影响的疾病，如代谢性疾病，特别是2型糖尿病。
• [EN] MTH1 INHIBITORS FOR TREATMENT OF CANCER<br/>[FR] INHIBITEURS MTH1 POUR LE TRAITEMENT DU CANCER
  申请人：THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING

  公开号：WO2015187088A1

  公开（公告）日：2015-12-10

  A compound of formula I, (I) or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer.

  公式I的化合物(I)或其药用可接受的盐。该化合物在治疗癌症中很有用。
• Thienopyridones as AMPK activators for the treatment of diabetes and obesity
  申请人：Iyengar R. Rajesh

  公开号：US20050038068A1

  公开（公告）日：2005-02-17

  The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.

  本发明涉及激活AMP-激活蛋白激酶（AMPK）的化合物，包括制备这些化合物、含有这些化合物的组合物以及利用这些化合物在预防或治疗糖尿病、代谢综合征和肥胖等疾病中的用途。